LYEL filings
Corporate insider profile
Gary K. Lee Filing Activity
Latest reported as Chief Scientific Officer of Lyell Immunopharma, Inc. (LYEL).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$26,979.92
- Latest transaction
- Aug 21, 2026
Affiliated corporations
Reported company relationships
Transaction history
